To be able to use the full range of Shopware 6, we recommend activating Javascript in your browser.

Structure of HIV-1 gag p17 20-28 (HLA-A*03:01)

Infectious disease

HIV-1 gag p17 20-28 (HLA-A*03:01) RLRPGGKKK

Product number: EP11256_1

€105.00*

Prices excl. VAT plus shipping costs

Available, delivery time: 1-3 days

sterile and endotoxin free

Delivery Format: The product is supplied freeze dried.

Purity: 95% HPLC-MS

Caution: For research use only. Not for use in humans.

Amount in mg

1

Add to Cart

Description

RLRPGGKKK is a linear peptidic epitope (epitope ID54741) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity and tested in T cell assays

TechData

Sequence:	RLRPGGKKK
Gene:	gag
Delivery:	1-3 days
C-Terminus:	OH
N-Terminus:	H
Amount:	1 mg
Counterion:	TFA
Protein:	Gag polyprotein
Species:	Human immunodeficiency virus 1 (HIV-1)
Allele:	HLA-A*03:01
Application:	Flow Cytometry, Immunohistochemistry
Indication:	Infectious disease
Purity:	95% HPLC-MS

Documents

Storage and handling of peptides

Probing of membranes with HRP

More HIV gag proteins

HIV Gag 150-158 (HLA-A*02:01)

HIV Gag 150-158 (HLA-A*02:01)

This peptide has a high avidity for CD8 T cells, and can be used in the analysis of individual antigen-specific T cells. This product is a MHC pentamer of peptide/MHC complex composed Gag-derived peptide of RTLNAWVKV sequence covering 150-158 and A*02:01 molecule.

From €105.00*

HIV gag 197-205 (H-2 Kd)

HIV gag 197-205 (H-2 Kd)

Antigen Peptide Gag Pol polyprotein H-2 Kd (AMQMLKETI) for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*

HIV Gag 433-440 (HLA-A*02:01)

HIV Gag 433-440 (HLA-A*02:01)

Therapeutic vaccination of chronically infected HIV-1 subjects was evaluated as a means of halting disease progression. A subdominant peptide vaccine containing 15 CTL epitopes and 3 helper T-cell peptides along with an adjuvant was delivered to 18 infected subjects. Using IFN-? EliSpot, 9 new T-cell responses were detected in 6/14 subjects whose viral loads (VL) remained stable. 7/10 CTL and other pre-existing responses, however, were not significantly detected. Gag433, FLGKIWPS, is a CTL epitope sequence used as a vaccine component.

From €105.00*

HIV Gag 50-59 (HLA-A*02:01)

HIV Gag 50-59 (HLA-A*02:01)

SLFNTVATLY is a linear peptidic epitope (epitope ID127083) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assay and MHC ligand assays

From €105.00*

HIV Gag 77-85 (HLA-A*02:01)

HIV Gag 77-85 (HLA-A*02:01)

SLFNTVATL is a linear peptidic epitope (epitope ID131070) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*

HIV gag 79-86 (HLA-A*29:02)

HIV gag 79-86 (HLA-A*29:02)

LYNTVATLY is a linear peptidic epitope (epitope ID126652) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1, tested in MHC ligand assays

From €105.00*

HIV gag p17 28-36 (HLA-A*24)

HIV gag p17 28-36 (HLA-A*24)

The peptide HIV gag p17 28-36 (HLA-A*24) with the amino acid sequence KYKLKHIVW is a linear peptidic epitope (epitope ID 34482) studied as part of Gag polyprotein (UniProt:P04591) from Lentivirus humimdef1.HIV gag p17 28-36 (HLA-A*24) has been studied for immune reactivity in publications and has been tested in T cell assays.

From €105.00*

HIV gag p24 128-135 (HLA-B*08:01)

HIV gag p24 128-135 (HLA-B*08:01)

The peptide HIV gag p24 128-135 (HLA-B*08:01) with the amino acid sequence EIYKRWII is a linear peptidic epitope (epitope ID 12616) studied as part of Gag polyprotein (UniProt:P04591) from Lentivirus humimdef1 and Gag-Pol polyprotein (UniProt:P04585) from Lentivirus humimdef1.HIV gag p24 128-135 (HLA-B*08:01) has been studied for immune reactivity in publications and has been tested in T cell assays.

From €105.00*

HIV Gag p24 128-136 (HLA-B*08:01)

HIV Gag p24 128-136 (HLA-B*08:01)

#

From €105.00*

HIV gag p24 223–231 (HLA-B*07:02)

HIV gag p24 223–231 (HLA-B*07:02)

GPGHKARVL is a linear peptidic epitope (epitope ID21635) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Antigen Peptide HIV gag p24 223–231 (HLA-B*07:02) GPGHKARVL for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

From €105.00*

HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G

HIV p24 gag 176-184 mutant (HLA-B*53:01) 183G

#

From €105.00*

HIV p24-Gag 263-272 (HLA-B*27:05)

HIV p24-Gag 263-272 (HLA-B*27:05)

KRWIILGLNK is a linear peptidic epitope (epitope ID33250) studied as part of Gag-Pol polyprotein from Human immunodeficiency virus 1 and Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays Single peptide HIV p24-Gag (HLA-B*27:05) 263-272 (KRWIILGLNK) for stimulation of human HIV p24-Gag(263-272)-specific CD8+ T-cells.

From €105.00*

HIV p24-Gag 30-40 (HLA-B*57:01)

HIV p24-Gag 30-40 (HLA-B*57:01)

HIV p24-Gag peptide KAFSPEVIPMF (HLA-B*5701) is a single peptide for stimulation of T cells. The peptide from human immunodeficiency virus 1 (HIV-1) p24 group-specific antigen (Gag) is synthesized as it is presented by the MHC class I HLA-B*5701 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.

From €105.00*

Tip

HIV-1 B Gag Peptide Pool

HIV-1 B Gag Peptide Pool

Pool of 123 peptides derived from a peptide scan (15mers with 11 aa overlap) through Gag polyprotein (Uni-Prot ID P04591) of Human immunodeficiency virus type 1 group M subtype B (isolate HXB2) (HIV-1). One unit allows the stimulation of 2,5 x 108 cells.

€316.90*

HIV-1 gag p24 19-27 (HLA-A*02:01)

HIV-1 gag p24 19-27 (HLA-A*02:01)

TLNAWVKVV is a linear peptidic epitope (epitope ID64961) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*

HIV-1 gag p24 261-269 (HLA-B*08:01)

HIV-1 gag p24 261-269 (HLA-B*08:01)

GEIYKRWII is a linear peptidic epitope (epitope ID19313) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assay and MHC ligand assays

From €105.00*

HIV-1 Gag p24 263-272 (HLA-B*27:05)

HIV-1 Gag p24 263-272 (HLA-B*27:05)

KRWIIMGLNK is a linear peptidic epitope (epitope ID184136) studied as part of Gag polyprotein from Human immunodeficiency virus 1. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays

From €105.00*